Article Information
History
- June 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Caitlin Monaghan, PhD*,1,
- John W. Larkin, PhD*,1,
- Sheetal Chaudhuri, MS1,7,
- Hao Han, MS1,
- Yue Jiao, PhD1,
- Kristine M. Bermudez2,
- Eric D. Weinhandl, PhD2,
- Ines A. Dahne-Steuber2,
- Kathleen Belmonte3,
- Luca Neri, MD, PhD4,
- Peter Kotanko, MD, FASN5,6,
- Jeroen P. Kooman, MD, PhD7,
- Jeffrey L. Hymes, MD2,
- Robert J. Kossmann, MD, FACP, FASN2,
- Len A. Usvyat, PhD1,† and
- Franklin W. Maddux, MD, FACP8
- 1Fresenius Medical Care, Global Medical Office, Waltham, United States
- 2Fresenius Medical Care North America, Medical Office, Waltham, United States
- 3Fresenius Kidney Care, Waltham, United States
- 4Fresenius Medical Care Deutschland GmbH, EMEA Medical Office, Bad Homburg, Germany
- 5Renal Research Institute, New York, United States
- 6Icahn School of Medicine at Mount Sinai, New York, United States
- 7Maastricht University Medical Center, Maastricht, The Netherlands
- 8Fresenius Medical Care AG & Co. KGaA, Global Medical Office, Bad Homburg, Germany
- ↵†Corresponding Author:
Len A. Usvyat, PhD; Fresenius Medical Care, Global Medical Office; 920 Winter Street, Waltham, MA, 02451 USA; Phone: (+1) 781-699-2535; E-Mail: len.usvyat{at}fmc-na.com
Posted June 17, 2020.
Artificial Intelligence for COVID-19 Risk Classification in Kidney Disease: Can Technology Unmask an Unseen Disease?
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos